| |
| |
|
| Insider
Information: |
Valantine Hannah |
| Relationship: |
|
| City: |
Menlo Park |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
28,655 |
|
|
Indirect Shares
|
3,433 |
|
|
| Direct
Value |
$294,540 |
|
|
|
Indirect Value
|
$92,794 |
|
|
| Total
Shares |
32,088 |
|
|
| Total
Value |
$387,334 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Caredx, Inc. |
CDNA |
Director |
2023-06-16 |
26,891 |
2021-07-01 |
0 |
Premium* |
|
|
Bridgebio Pharma, Inc. |
BBIO |
|
2024-02-15 |
1,764 |
2024-02-15 |
3,433 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BBIO |
Bridgebio Pharma, Inc. |
|
– • – |
2024-02-15 |
4 |
AS |
$37.75 |
$110,041 |
D/D |
(2,915) |
1,764 |
0 |
% |
|
| BBIO |
Bridgebio Pharma, Inc. |
|
– • – |
2024-02-15 |
4 |
OE |
$8.45 |
$24,632 |
D/D |
2,915 |
4,679 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
|
– • – |
2024-01-16 |
4 |
AS |
$37.97 |
$110,683 |
D/D |
(2,915) |
1,764 |
0 |
% |
|
| BBIO |
Bridgebio Pharma, Inc. |
|
– • – |
2024-01-16 |
4 |
OE |
$8.45 |
$24,632 |
D/D |
2,915 |
4,679 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
Director |
– • – |
2023-12-15 |
4 |
AS |
$36.12 |
$105,290 |
D/D |
(2,915) |
1,764 |
0 |
% |
|
| BBIO |
Bridgebio Pharma, Inc. |
Director |
– • – |
2023-12-15 |
4 |
OE |
$8.45 |
$24,632 |
D/D |
2,915 |
4,679 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
Director |
– • – |
2023-11-15 |
4 |
AS |
$30.00 |
$87,450 |
D/D |
(2,915) |
1,764 |
0 |
% |
|
| BBIO |
Bridgebio Pharma, Inc. |
Director |
– • – |
2023-11-15 |
4 |
OE |
$8.45 |
$24,632 |
D/D |
2,915 |
4,679 |
0 |
- |
|
| CDNA |
Caredx, Inc. |
Director |
– • – |
2023-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
18,844 |
26,891 |
0 |
- |
|
| CDNA |
Caredx, Inc. |
Director |
– • – |
2023-01-06 |
4 |
A |
$0.00 |
$0 |
D/D |
676 |
8,047 |
0 |
- |
|
| CDNA |
Caredx, Inc. |
Director |
– • – |
2022-10-04 |
4 |
A |
$0.00 |
$0 |
D/D |
422 |
7,371 |
0 |
- |
|
| CDNA |
Caredx, Inc. |
Director |
– • – |
2022-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
325 |
6,949 |
0 |
- |
|
| CDNA |
Caredx, Inc. |
Director |
– • – |
2022-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
4,863 |
6,624 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
Director |
– • – |
2021-12-29 |
4 |
B |
$14.23 |
$25,102 |
D/D |
1,764 |
1,764 |
2.39 |
% |
|
| BBIO |
Bridgebio Pharma, Inc. |
|
– • – |
2021-12-28 |
4 |
B |
$12.68 |
$44,476 |
I/I |
3,433 |
3,433 |
0.01 |
% |
|
| CDNA |
Caredx, Inc. |
Director |
– • – |
2021-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
131 |
1,761 |
0 |
- |
|
| CDNA |
Caredx, Inc. |
Director |
– • – |
2021-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,630 |
1,630 |
0 |
- |
|
17 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
